chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pustule
Clinical narrative: Started out as 2 pustules and then turned red; Red mark/2 inches in diameter; This spontaneous case was reported by a consumer and describes the occurrence of PUSTULE (Started out as 2 pustules and then turned red) and ERYTHEMA (Red mark/2 inches in diameter) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PUSTULE (Started out as 2 pustules and then turned red) and ERYTHEMA (Red mark/2 inches in diameter). At the time of the report, PUSTULE (Started out as 2 pustules and then turned red) and ERYTHEMA (Red mark/2 inches in diameter) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.   No treatment information was provided.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site discomfort, Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Very warm; arm was swollen; very red,; discomfort from the actual shot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOMFORT (discomfort from the actual shot), VACCINATION SITE WARMTH (Very warm), VACCINATION SITE SWELLING (arm was swollen) and VACCINATION SITE ERYTHEMA (very red,) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no relevant medical history provided).    On 02-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Jan-2021, the patient experienced VACCINATION SITE DISCOMFORT (discomfort from the actual shot). On 11-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Very warm), VACCINATION SITE SWELLING (arm was swollen) and VACCINATION SITE ERYTHEMA (very red,). On 04-Jan-2021, VACCINATION SITE DISCOMFORT (discomfort from the actual shot) had resolved. At the time of the report, VACCINATION SITE WARMTH (Very warm), VACCINATION SITE SWELLING (arm was swollen) and VACCINATION SITE ERYTHEMA (very red,) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication were not reported by the reporter. Treatment details included ice, antibiotics and Benadryl.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Chills, Eructation, Fatigue, Myalgia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), ABDOMINAL DISCOMFORT (Stomach upset), ERUCTATION (Burping), FATIGUE (Fatigue) and MYALGIA (Bad body aches) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported by the reporter.  Concomitant products included LISINOPRIL, ROSUVASTATIN CALCIUM (CRESTOR), TRIAMCINOLONE ACETONIDE (NASACORT), CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), SALBUTAMOL (ALBUTEROL HFA), COQ10 [ASCORBIC ACID;BETACAROTENE;CUPRIC OXIDE;MANGANESE SULFATE;SELENIUM;TOCOPHERYL ACETATE;UBIDECARENONE;ZINC OXIDE] and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), ABDOMINAL DISCOMFORT (Stomach upset), ERUCTATION (Burping), FATIGUE (Fatigue), MYALGIA (Bad body aches), CHILLS (Chills) and PYREXIA (Fever). On an unknown date, the patient experienced NAUSEA (Nausea). At the time of the report, PAIN IN EXTREMITY (Sore arm), ABDOMINAL DISCOMFORT (Stomach upset), FATIGUE (Fatigue), MYALGIA (Bad body aches) and CHILLS (Chills) had not resolved and ERUCTATION (Burping), NAUSEA (Nausea) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment included Tylenol 500 mg.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity, Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), ABDOMINAL DISCOMFORT (Stomach upset), ERUCTATION (Burping), FATIGUE (Fatigue) and MYALGIA (Bad body aches) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported by the reporter.  Concomitant products included LISINOPRIL, ROSUVASTATIN CALCIUM (CRESTOR), TRIAMCINOLONE ACETONIDE (NASACORT), CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), SALBUTAMOL (ALBUTEROL HFA), COQ10 [ASCORBIC ACID;BETACAROTENE;CUPRIC OXIDE;MANGANESE SULFATE;SELENIUM;TOCOPHERYL ACETATE;UBIDECARENONE;ZINC OXIDE] and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), ABDOMINAL DISCOMFORT (Stomach upset), ERUCTATION (Burping), FATIGUE (Fatigue), MYALGIA (Bad body aches), CHILLS (Chills) and PYREXIA (Fever). On an unknown date, the patient experienced NAUSEA (Nausea). At the time of the report, PAIN IN EXTREMITY (Sore arm), ABDOMINAL DISCOMFORT (Stomach upset), FATIGUE (Fatigue), MYALGIA (Bad body aches) and CHILLS (Chills) had not resolved and ERUCTATION (Burping), NAUSEA (Nausea) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment included Tylenol 500 mg.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth, Vaccination site pruritus
Clinical narrative: warm to touch; itchy; a red area at the injection site; it is a little smaller than palm size; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of INJECTION SITE WARMTH (warm to touch), VACCINATION SITE PRURITUS (itchy), INJECTION SITE ERYTHEMA (a red area at the injection site) and INJECTION SITE SWELLING (it is a little smaller than palm size) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history provided.).    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced INJECTION SITE WARMTH (warm to touch), VACCINATION SITE PRURITUS (itchy), INJECTION SITE ERYTHEMA (a red area at the injection site) and INJECTION SITE SWELLING (it is a little smaller than palm size). At the time of the report, INJECTION SITE WARMTH (warm to touch), VACCINATION SITE PRURITUS (itchy) and INJECTION SITE SWELLING (it is a little smaller than palm size) outcome was unknown and INJECTION SITE ERYTHEMA (a red area at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication details were not reported by the reporter. Treatment included Pepcid.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Lethargy, Pain in extremity
Clinical narrative: Lethargy; Sore arm; Headache; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (Lethargy), PAIN IN EXTREMITY (Sore arm), HEADACHE (Headache) and FATIGUE (Tiredness) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20-2A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in October 2019.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced LETHARGY (Lethargy), PAIN IN EXTREMITY (Sore arm), HEADACHE (Headache) and FATIGUE (Tiredness). At the time of the report, LETHARGY (Lethargy), PAIN IN EXTREMITY (Sore arm), HEADACHE (Headache) and FATIGUE (Tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication were not reported by the reporter. Treatment details was not reported by the reporter.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: adverse reaction; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (adverse reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (adverse reaction). At the time of the report, VACCINATION COMPLICATION (adverse reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment related information has been reported.; Sender's Comments: Very limited information regarding this event has been provided at this time.  Further information has been requested.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Body temperature, Chills, Decreased appetite, Fatigue
Clinical narrative: Tired; fever (99.4°F) for 3 days; No energy; No appetite; Felt rough; Nausea; Chills; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 19-Jan-2021. The most recent information was received on 07-Jun-2021 and was forwarded to Moderna on 07-Jun-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (No energy), DECREASED APPETITE (No appetite), FEELING ABNORMAL (Felt rough), NAUSEA (Nausea) and CHILLS (Chills) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Allergy to sulfa) and Allergic reaction to antibiotics (Allergy to Amoxicillin).    On 15-Jan-2021 at 8:45 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced ASTHENIA (No energy), DECREASED APPETITE (No appetite), FEELING ABNORMAL (Felt rough), NAUSEA (Nausea), CHILLS (Chills) and PYREXIA (fever (99.4°F) for 3 days). On 19-Jan-2021, the patient experienced FATIGUE (Tired). On 17-Jan-2021, ASTHENIA (No energy), DECREASED APPETITE (No appetite), FEELING ABNORMAL (Felt rough), NAUSEA (Nausea) and CHILLS (Chills) had resolved. On 19-Jan-2021, PYREXIA (fever (99.4°F) for 3 days) had resolved. At the time of the report, FATIGUE (Tired) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Nov-2020, SARS-CoV-2 test: positive (Positive) rapid & sent to state. On 16-Jan-2021, Body temperature: 99.4°f (High) 99.4°F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment related information has been reported.  Patient was likely to buy hearing aid for left ear.   This case was linked to MOD-2021-053892 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 07-Jun-2021: Follow-up received on 07-Jun-2021 contains Patient demographic details, Medical History, second dose details, vaccine information.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Nausea, Pyrexia, SARS-CoV-2 test
Clinical narrative: Tired; fever (99.4°F) for 3 days; No energy; No appetite; Felt rough; Nausea; Chills; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 19-Jan-2021. The most recent information was received on 07-Jun-2021 and was forwarded to Moderna on 07-Jun-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (No energy), DECREASED APPETITE (No appetite), FEELING ABNORMAL (Felt rough), NAUSEA (Nausea) and CHILLS (Chills) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Allergy to sulfa) and Allergic reaction to antibiotics (Allergy to Amoxicillin).    On 15-Jan-2021 at 8:45 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced ASTHENIA (No energy), DECREASED APPETITE (No appetite), FEELING ABNORMAL (Felt rough), NAUSEA (Nausea), CHILLS (Chills) and PYREXIA (fever (99.4°F) for 3 days). On 19-Jan-2021, the patient experienced FATIGUE (Tired). On 17-Jan-2021, ASTHENIA (No energy), DECREASED APPETITE (No appetite), FEELING ABNORMAL (Felt rough), NAUSEA (Nausea) and CHILLS (Chills) had resolved. On 19-Jan-2021, PYREXIA (fever (99.4°F) for 3 days) had resolved. At the time of the report, FATIGUE (Tired) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Nov-2020, SARS-CoV-2 test: positive (Positive) rapid & sent to state. On 16-Jan-2021, Body temperature: 99.4°f (High) 99.4°F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment related information has been reported.  Patient was likely to buy hearing aid for left ear.   This case was linked to MOD-2021-053892 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 07-Jun-2021: Follow-up received on 07-Jun-2021 contains Patient demographic details, Medical History, second dose details, vaccine information.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Paraesthesia oral
Clinical narrative: Mouth tingling / Lips tingling; Horrible taste of metal in mouth; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PARAESTHESIA ORAL (Mouth tingling / Lips tingling) and DYSGEUSIA (Horrible taste of metal in mouth) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced PARAESTHESIA ORAL (Mouth tingling / Lips tingling) and DYSGEUSIA (Horrible taste of metal in mouth). At the time of the report, PARAESTHESIA ORAL (Mouth tingling / Lips tingling) and DYSGEUSIA (Horrible taste of metal in mouth) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       About 20 minutes after receiving the shot, the patient started feeling tingling around her month and lips. In addition, she had a horrible taste of metal in her mouth.  No relevant concomitant medications were reported.    No treatment information was provided.   Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pruritus, Vaccination site erythema
Clinical narrative: swelling in her armpit; very itchy; arm very red; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (very itchy), LYMPHADENOPATHY (swelling in her armpit) and VACCINATION SITE ERYTHEMA (arm very red) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.  Concurrent medical conditions included Diabetes and Blood pressure. Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) and CLONAZEPAM for an unknown indication.   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (very itchy), LYMPHADENOPATHY (swelling in her armpit) and VACCINATION SITE ERYTHEMA (arm very red). At the time of the report, PRURITUS (very itchy), LYMPHADENOPATHY (swelling in her armpit) and VACCINATION SITE ERYTHEMA (arm very red) outcome was unknown.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.    Concomitantly patient was taking steroids, blood pressure medications and diabetes medications. No treatment related information has been reported.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: a little bit of itchiness at injection site; a little bit of swelling at injection site; a little bit of redness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (a little bit of itchiness at injection site), VACCINATION SITE SWELLING (a little bit of swelling at injection site) and VACCINATION SITE ERYTHEMA (a little bit of redness at injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (a little bit of itchiness at injection site), VACCINATION SITE SWELLING (a little bit of swelling at injection site) and VACCINATION SITE ERYTHEMA (a little bit of redness at injection site). At the time of the report, VACCINATION SITE PRURITUS (a little bit of itchiness at injection site), VACCINATION SITE SWELLING (a little bit of swelling at injection site) and VACCINATION SITE ERYTHEMA (a little bit of redness at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment related information has been reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Myalgia, Pyrexia
Clinical narrative: Body ache; Fatigue; Chills; Fever 102; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body ache), FATIGUE (Fatigue), CHILLS (Chills) and PYREXIA (Fever 102) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced MYALGIA (Body ache), FATIGUE (Fatigue), CHILLS (Chills) and PYREXIA (Fever 102). At the time of the report, MYALGIA (Body ache), FATIGUE (Fatigue), CHILLS (Chills) and PYREXIA (Fever 102) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Jan-2021, Body temperature: 102.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment medication included acetaminophen 4-6 daily.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Ear pain
Clinical narrative: pain in the ear; This spontaneous case was reported by an other health care professional and describes the occurrence of EAR PAIN (pain in the ear) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EAR PAIN (pain in the ear). At the time of the report, EAR PAIN (pain in the ear) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided. Treatment information was not reported.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Arm is little sore at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of   in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes, Hypertension and Gout. Concomitant products included METFORMIN, AMLODIPINE and VALSARTAN for an unknown indication.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not reported.
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Blood pressure measurement, Disorientation, Fatigue, Hypertension
Clinical narrative: Very disoriented; Equilibrium was off; BP was 244; Extreme fatigue; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DISORIENTATION (Very disoriented), BALANCE DISORDER (Equilibrium was off), HYPERTENSION (BP was 244) and FATIGUE (Extreme fatigue) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     The patient's past medical history included Hysterectomy.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jan-2021, the patient experienced DISORIENTATION (Very disoriented), BALANCE DISORDER (Equilibrium was off), HYPERTENSION (BP was 244) and FATIGUE (Extreme fatigue). On 14-Jan-2021, DISORIENTATION (Very disoriented), BALANCE DISORDER (Equilibrium was off), HYPERTENSION (BP was 244) and FATIGUE (Extreme fatigue) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Jan-2021, Blood pressure measurement: 244.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient was 40 years old when she had a hysterectomy, which was the only surgery she had in her life. That time she felt her equilibrium was off, which lasted days. Not until 16-Jan-2021, she was able to walk unassisted. She saw her physician on 12-Jan-2021 and her pressure had gone down. She was feeling better. She was not allergic to anything. The patient had a follow up appointment with her physician on 26-Jan-2021. Concomitant medications were not provided. Treatment information was not reported.
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: fever of 103 F degrees; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever of 103 F degrees) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever of 103 F degrees). At the time of the report, PYREXIA (fever of 103 F degrees) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Vaccination site induration, Vaccination site pain, Vaccination site swelling
Clinical narrative: COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced VACCINATION SITE PAIN (Mild soreness at the injection site) and VACCINATION SITE SWELLING (Slight swelling at the injection site). On 19-Jan-2021, the patient experienced INSOMNIA (Difficulty sleeping), VACCINATION SITE INDURATION (Muscle being hard as rock), VACCINATION SITE PAIN (Pain at injection site/very tender) and VACCINATION SITE SWELLING (Arm more swollen than last week). On 13-Jan-2021, VACCINATION SITE PAIN (Mild soreness at the injection site) and VACCINATION SITE SWELLING (Slight swelling at the injection site) had resolved. At the time of the report, INSOMNIA (Difficulty sleeping), VACCINATION SITE INDURATION (Muscle being hard as rock), VACCINATION SITE PAIN (Pain at injection site/very tender) and VACCINATION SITE SWELLING (Arm more swollen than last week) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The concomitant medications and treatment details were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 13-Apr-2021: Follow-up information received on 13-Apr-2021 does not contain any new information. On 23-Apr-2021: Follow-up information received on 23-Apr-2021 does not contain an new information
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Head discomfort, Paraesthesia
Clinical narrative: facial numbness and tingling; brain fog: my head was constantly heavy; felt lightheaded/dizzy; A spontaneous case was received from the consumer concerning female patient of 31 years who received Moderna's  COVID-19 vaccine and experienced  lightheaded and dizzy/Dizziness, brain fog: my head was constantly heavy/Head discomfort, facial numbness and tingling/Paraesthesia .  The patient's medical history was not provided. No relevant concomitant medications was reported.  On 29-Jan-2021 prior to the onset of the events, the patient received first of the two planned doses of mRNA-1273 (Lot Number:011520A) on the left arm for the prophylaxis of COVID-19 infection.  On 19-Jan-2021 the patient experienced anticipating a sore arm, but she felt lightheaded and dizzy, which lasted a day or two. On 01Jan2021, she had a brain fog; her head was constantly heavy. She can function cognitively, but it takes more to concentrate and accomplish things. She started developing facial numbness and tingling on 13Jan2021. She reports it happens every day most of the day.  Action taken with the second dose of mRNA-1273 in response to the event was not reported.  The outcome of the events, lightheaded and dizzy/Dizziness was resolved and brain fog: my head was constantly heavy/Head discomfort, facial numbness and tingling/Paraesthesia  was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Cough, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: cough; injection site was very itchy; injection site was swollen; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (cough), VACCINATION SITE PRURITUS (injection site was very itchy) and VACCINATION SITE SWELLING (injection site was swollen) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure. Concomitant products included METHYLPHENIDATE HYDROCHLORIDE (RITALIN) for an unknown indication.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On 20-Jan-2021, the patient experienced COUGH (cough), VACCINATION SITE PRURITUS (injection site was very itchy) and VACCINATION SITE SWELLING (injection site was swollen). At the time of the report, COUGH (cough), VACCINATION SITE PRURITUS (injection site was very itchy) and VACCINATION SITE SWELLING (injection site was swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.    Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Dizziness postural, Nausea, Pain in extremity
Clinical narrative: pain all the way down to wrist; diizziness was very bothersome, had to lie flat to feel better; Backache; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain all the way down to wrist), DIZZINESS POSTURAL (diizziness was very bothersome, had to lie flat to feel better), BACK PAIN (Backache) and NAUSEA (Nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (pain all the way down to wrist), DIZZINESS POSTURAL (diizziness was very bothersome, had to lie flat to feel better), BACK PAIN (Backache) and NAUSEA (Nausea). At the time of the report, PAIN IN EXTREMITY (pain all the way down to wrist), DIZZINESS POSTURAL (diizziness was very bothersome, had to lie flat to feel better), BACK PAIN (Backache) and NAUSEA (Nausea) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient did not seek medical treatment.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash
Clinical narrative: Vaccination site pruritus; Vaccination site rash; This spontaneous case was reported by a consumer and describes the occurrence of   in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no relevant medical history provided).    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Myalgia, Pain
Clinical narrative: pains/other pain; muscle aches; Headache; Arm pain; Fatigue; Fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain), PAIN (pains/other pain), FATIGUE (Fatigue), PYREXIA (Fever) and CHILLS (chills) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm pain), FATIGUE (Fatigue), PYREXIA (Fever) and CHILLS (chills). On 20-Jan-2021, the patient experienced HEADACHE (Headache). On an unknown date, the patient experienced PAIN (pains/other pain) and MYALGIA (muscle aches). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Arm pain), PAIN (pains/other pain), FATIGUE (Fatigue), PYREXIA (Fever), CHILLS (chills), HEADACHE (Headache) and MYALGIA (muscle aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: pains/other pain; muscle aches; Headache; Arm pain; Fatigue; Fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain), PAIN (pains/other pain), FATIGUE (Fatigue), PYREXIA (Fever) and CHILLS (chills) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm pain), FATIGUE (Fatigue), PYREXIA (Fever) and CHILLS (chills). On 20-Jan-2021, the patient experienced HEADACHE (Headache). On an unknown date, the patient experienced PAIN (pains/other pain) and MYALGIA (muscle aches). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Arm pain), PAIN (pains/other pain), FATIGUE (Fatigue), PYREXIA (Fever), CHILLS (chills), HEADACHE (Headache) and MYALGIA (muscle aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: Extremaly swelling glands on the neck; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Extremaly swelling glands on the neck) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2021, the patient experienced SWELLING (Extremaly swelling glands on the neck). At the time of the report, SWELLING (Extremaly swelling glands on the neck) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications details were not reported by the reported. Treatment details was not reported by the reporter.   Reporter did not allow further contact
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Injected limb mobility decreased, Lymphadenopathy, Pain, Vaccination site pain
Clinical narrative: could not lift the arm and that had no use of left arm; Sweats; pain went from elbow up to the neck , front chest; pain in the arm where the vaccine was given; lymph node was the size of an egg; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION SITE PAIN (pain in the arm where the vaccine was given), PAIN (pain went from elbow up to the neck , front chest), LYMPHADENOPATHY (lymph node was the size of an egg), INJECTED LIMB MOBILITY DECREASED (could not lift the arm and that had no use of left arm) and HYPERHIDROSIS (Sweats) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     Concomitant products included Allopyranol, Hydroclorizide, LISINOPRIL and METOPROLOL for an unknown indication.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced VACCINATION SITE PAIN (pain in the arm where the vaccine was given), PAIN (pain went from elbow up to the neck , front chest) and LYMPHADENOPATHY (lymph node was the size of an egg). On 17-Jan-2021, the patient experienced INJECTED LIMB MOBILITY DECREASED (could not lift the arm and that had no use of left arm) and HYPERHIDROSIS (Sweats). At the time of the report, VACCINATION SITE PAIN (pain in the arm where the vaccine was given), PAIN (pain went from elbow up to the neck , front chest), INJECTED LIMB MOBILITY DECREASED (could not lift the arm and that had no use of left arm) and HYPERHIDROSIS (Sweats) was resolving and LYMPHADENOPATHY (lymph node was the size of an egg) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment included none.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: extremely heated arm at the injection site; A spontaneous report was received from consumer concerning a 81 Years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced vaccination site warmth.   The patient's medical history was not provided. No relevant concomitant medications were reported.      On 15 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: 041L20A) intramuscularly in the arm for prophylaxis of COVID-19 infection.    On 15 Jan 2021, The patient experienced extremely heated arm on the injection site.   Laboratory details are not provided.    The patient was treated with Benadryl.     Action taken with mRNA-1273 in response to the events was not reported.  The outcome of the event was unknown.; Reporter's Comments: This case concerns an 81-year-old female who experienced a nonserious unexpected event of vaccination site warmth.  The events occurred the same day as the first dose of mRNA-1273 (lot # 041L20A). The patient was treated with Benadryl.  Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site rash, Vaccination site swelling, Vaccination site warmth
Clinical narrative: The site of injection is hot and swollen; Redness and rash at the site of injection; Redness and rash at the site of injection; The site of injection is hot and swollen; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (The site of injection is hot and swollen), VACCINATION SITE ERYTHEMA (Redness and rash at the site of injection), VACCINATION SITE RASH (Redness and rash at the site of injection) and VACCINATION SITE SWELLING (The site of injection is hot and swollen) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced VACCINATION SITE WARMTH (The site of injection is hot and swollen), VACCINATION SITE ERYTHEMA (Redness and rash at the site of injection), VACCINATION SITE RASH (Redness and rash at the site of injection) and VACCINATION SITE SWELLING (The site of injection is hot and swollen). At the time of the report, VACCINATION SITE WARMTH (The site of injection is hot and swollen), VACCINATION SITE ERYTHEMA (Redness and rash at the site of injection), VACCINATION SITE RASH (Redness and rash at the site of injection) and VACCINATION SITE SWELLING (The site of injection is hot and swollen) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.   Reporter did not allow further contact
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Bedridden, Bone pain, Chest discomfort, Chills
Clinical narrative: a little itchiness on the same arm of injection; experienced chills; very bad headaches; felt like she had the flu; bone pain; stay in bed all day; feel very anxious; her hands started to sweat; numbness on face and tongue; tingle on face and tongue like she had anesthesia; tingle on face and tongue like she had anesthesia; tongue was bigger and dryness; tongue was bigger and dryness; thirsty; pressure on chest; dizziness; This spontaneous case was reported by an other caregiver and describes the occurrence of ANXIETY (feel very anxious), HYPERHIDROSIS (her hands started to sweat), HYPOAESTHESIA (numbness on face and tongue), PARAESTHESIA (tingle on face and tongue like she had anesthesia) and PARAESTHESIA ORAL (tingle on face and tongue like she had anesthesia) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced ANXIETY (feel very anxious), HYPERHIDROSIS (her hands started to sweat), HYPOAESTHESIA (numbness on face and tongue), PARAESTHESIA (tingle on face and tongue like she had anesthesia), PARAESTHESIA ORAL (tingle on face and tongue like she had anesthesia), SWOLLEN TONGUE (tongue was bigger and dryness), TONGUE DRY (tongue was bigger and dryness), THIRST (thirsty), CHEST DISCOMFORT (pressure on chest) and DIZZINESS (dizziness). On 17-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (felt like she had the flu), BEDRIDDEN (stay in bed all day), CHILLS (experienced chills), BONE PAIN (bone pain) and HEADACHE (very bad headaches). On 20-Jan-2021, the patient experienced INJECTION SITE PRURITUS (a little itchiness on the same arm of injection). On 16-Jan-2021, ANXIETY (feel very anxious), HYPERHIDROSIS (her hands started to sweat), HYPOAESTHESIA (numbness on face and tongue), PARAESTHESIA (tingle on face and tongue like she had anesthesia), PARAESTHESIA ORAL (tingle on face and tongue like she had anesthesia), SWOLLEN TONGUE (tongue was bigger and dryness), TONGUE DRY (tongue was bigger and dryness), THIRST (thirsty), CHEST DISCOMFORT (pressure on chest) and DIZZINESS (dizziness) had resolved. On 17-Jan-2021, INFLUENZA LIKE ILLNESS (felt like she had the flu), BEDRIDDEN (stay in bed all day), CHILLS (experienced chills), BONE PAIN (bone pain) and HEADACHE (very bad headaches) had resolved. At the time of the report, INJECTION SITE PRURITUS (a little itchiness on the same arm of injection) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Hyperhidrosis, Hypoaesthesia, Influenza like illness
Clinical narrative: a little itchiness on the same arm of injection; experienced chills; very bad headaches; felt like she had the flu; bone pain; stay in bed all day; feel very anxious; her hands started to sweat; numbness on face and tongue; tingle on face and tongue like she had anesthesia; tingle on face and tongue like she had anesthesia; tongue was bigger and dryness; tongue was bigger and dryness; thirsty; pressure on chest; dizziness; This spontaneous case was reported by an other caregiver and describes the occurrence of ANXIETY (feel very anxious), HYPERHIDROSIS (her hands started to sweat), HYPOAESTHESIA (numbness on face and tongue), PARAESTHESIA (tingle on face and tongue like she had anesthesia) and PARAESTHESIA ORAL (tingle on face and tongue like she had anesthesia) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced ANXIETY (feel very anxious), HYPERHIDROSIS (her hands started to sweat), HYPOAESTHESIA (numbness on face and tongue), PARAESTHESIA (tingle on face and tongue like she had anesthesia), PARAESTHESIA ORAL (tingle on face and tongue like she had anesthesia), SWOLLEN TONGUE (tongue was bigger and dryness), TONGUE DRY (tongue was bigger and dryness), THIRST (thirsty), CHEST DISCOMFORT (pressure on chest) and DIZZINESS (dizziness). On 17-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (felt like she had the flu), BEDRIDDEN (stay in bed all day), CHILLS (experienced chills), BONE PAIN (bone pain) and HEADACHE (very bad headaches). On 20-Jan-2021, the patient experienced INJECTION SITE PRURITUS (a little itchiness on the same arm of injection). On 16-Jan-2021, ANXIETY (feel very anxious), HYPERHIDROSIS (her hands started to sweat), HYPOAESTHESIA (numbness on face and tongue), PARAESTHESIA (tingle on face and tongue like she had anesthesia), PARAESTHESIA ORAL (tingle on face and tongue like she had anesthesia), SWOLLEN TONGUE (tongue was bigger and dryness), TONGUE DRY (tongue was bigger and dryness), THIRST (thirsty), CHEST DISCOMFORT (pressure on chest) and DIZZINESS (dizziness) had resolved. On 17-Jan-2021, INFLUENZA LIKE ILLNESS (felt like she had the flu), BEDRIDDEN (stay in bed all day), CHILLS (experienced chills), BONE PAIN (bone pain) and HEADACHE (very bad headaches) had resolved. At the time of the report, INJECTION SITE PRURITUS (a little itchiness on the same arm of injection) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.